FDA Inspection 1181739 — Optego Vision USA, Inc.
The FDA completed an inspection of Optego Vision USA, Inc. on Aug 24, 2022 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Tucson, AZ (United States)